Episode 2: Fighting AML in Young Patients: New Research & the Future of CAR-T
AML isn’t just a disease of older adults. In this episode with Dr Emily Hsieh, we explore how treatment differs for pediatric AML patients and the promising research - including CAR-T therapy - that could change the game.
Thank you for listening! Reach out to Mary at mary@healthtree.org if you are interested in joining our Pediatric Advisory Board or to share your thoughts about today's episode.
To keep learning about today's topic, check out these additional resources mentioned in today's episode!
If you want to talk to other listeners about this episode, join HealthTree Connect below and start the conversation!
Mary Arnett
Mary joined HealthTree in 2022 as a part of HealthTree's team to help expand into all blood cancers. She now works as HealthTree's Volunteer & Community Outreach Manager, helping to engage and involve community members in HealthTree's mission. When she isn't working, she loves being the fun aunt to her 13 nieces and nephews, attending concerts, experimenting with new recipes in the kitchen, and traveling to explore new cities.
Dr. Emily Hsieh
Dr. Hsieh is a hematologist oncologist out of the Children's Hospital of Los Angeles. Her research focuses on developing cellular therapy clinical trials for relapsed hematologic malignancies.